bimo 12the study team should discuss these items with FDA prior to starting BIMO programming activities. 2. In order to avoid any last-minute snags while preparing the BIMO package, it isBIMO data is indispensable for pivotal trials that profile the safety and efficacy of a marketing application. Typically, the structure of BIMO submissions remains consistent across